Association between cardiovascular implantable electronic devices and tricuspid regurgitation: a case- control study  

作　　者：Yuan-yuan Zhang Yan Cheng Liang-rong Zheng Zhe-lan Zheng 

机构地区：[1]Department of Cardiovascular Ultrasonic Center,the First Affi liated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China [2]Department of Cardiology,the First Affi liated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China

出　　处：《World Journal of Emergency Medicine》2022年第5期403-405,共3页世界急诊医学杂志（英文）

基　　金：This work was supported by grants from the Planned Science and Technology Project of Zhejiang Province,China(2020KY216);Hangzhou City Health Science and Technique Program(OO20190126).

摘　　要：Cardiovascular implantable electronic devices(CIEDs)are widely used in the modern era.Every year,about 730,000 permanent pacemakers and 330,000 CIEDs are implanted worldwide.CIEDs have been known to increase the life expectancy of millions of people and improve their quality of life by controlling the heart rate and atrioventricular and interventricular synchronization and preventing sudden cardiac death.[1]The tricuspid valve consists of the annulus,leaflets,chordae tendineae,and papillary muscles.Interaction between the endocardial lead and any component of this structure can lead to tricuspid valve dysfunction,thereby resulting in tricuspid regurgitation(TR).[2]CIED-related TR has been shown to be an independent predictor of hospitalization for heart failure.[3,4]

关 键 词：TRICUSPID REGURGITATION VENTRICULAR 

分 类 号：R542.53[医药卫生—心血管疾病]